Effect of intravenous infusion of 15-methyl-PGF2α on plasma hormone levels during early pregnancy
- 1 February 1979
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 17 (2) , 313-322
- https://doi.org/10.1016/0090-6980(79)90051-0
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Treatment with a single vaginal suppository containing 15-methyl PGF2α methyl ester at expected time of menstruationProstaglandins, 1979
- A LONGITUDINAL STUDY OF THE FREE CORTISOL INDEX IN PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1976
- Radioimmunoassay of progesterone, 17-hydroxyprogesterone, estradiol-17β and prostaglandin F in human corpus luteumSteroids, 1975
- Hormone changes occurring during second trimester abortion induced with 15(S)-15-methyl prostaglandin F2αProstaglandins, 1975
- A RAPID 5 HOUR RADIOIMMUNOASSAY OF PROGESTERONE AND OESTRADIOL IN HUMAN PLASMAClinical Endocrinology, 1975
- PROSTAGLANDIN-F2α RECEPTOR IN HUMAN CORPORA LUTEAThe Lancet, 1974
- Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17α-hydroxyprogesterone in human pregnancyAmerican Journal of Obstetrics and Gynecology, 1973
- The prospects of PGs in postconceptional therapyProstaglandins, 1973
- Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2αProstaglandins, 1972
- Lognormal DistributionsNature, 1945